Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year …
RF Van Vollenhoven, S Ernestam, P Geborek… - The Lancet, 2009 - thelancet.com
Background New treatment strategies for early rheumatoid arthritis are evolving rapidly. We
aimed to compare addition of conventional disease-modifying antirheumatic drugs (…
aimed to compare addition of conventional disease-modifying antirheumatic drugs (…
Creating a culture of health: evolving healthcare systems and patient engagement
S Lindblad, S Ernestam, AD Van Citters… - … Journal of Medicine, 2017 - academic.oup.com
We all recognize that today’s healthcare megatrends are challenging to people, practitioners,
scientists, healthcare systems, governments and life science companies. This is …
scientists, healthcare systems, governments and life science companies. This is …
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis
…, J Lampa, M Heimbürger, S Ernestam… - Annals of the …, 2003 - ard.bmj.com
Background: Rheumatoid arthritis (RA) is a genetically complex disease where the response
to different treatments varies greatly between different patients. This is the case with the …
to different treatments varies greatly between different patients. This is the case with the …
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded …
…, P Geborek, K Forslind, K Albertsson, S Ernestam… - The Lancet, 2012 - thelancet.com
Background Analysis of the Swedish Farmacotherapy (Swefot) trial at 12 months showed
that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical outcome …
that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical outcome …
Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration
…, M Neovius, S Ernestam, S Lindblad… - Arthritis care & …, 2013 - Wiley Online Library
… Linkage of these register sources was performed using each patient’s personal identification
number, a unique identifier carried by each Swedish resident. Ethical approval was granted …
number, a unique identifier carried by each Swedish resident. Ethical approval was granted …
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial
…, H Wallin, M Seddighzadeh, S Ernestam… - Annals of the …, 2011 - ard.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …
Anti‐tumour necrosis factor (TNF)‐α therapy (etanercept) down‐regulates serum matrix metalloproteinase (MMP)‐3 and MMP‐1 in rheumatoid arthritis
AI Catrina, J Lampa, S Ernestam, E Af Klint… - …, 2002 - academic.oup.com
Objectives. Matrix metalloproteinases (MMPs) are cytokine‐modulated enzymes that play an
important role in the pathogenesis of rheumatoid arthritis (RA) by inducing bone resorption …
important role in the pathogenesis of rheumatoid arthritis (RA) by inducing bone resorption …
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
…, P Geborek, I Petersson, S Ernestam… - Annals of the …, 2015 - ard.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …
Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the …
MC Wick, S Ernestam, S Lindblad, J Bratt… - Scandinavian journal …, 2005 - Taylor & Francis
Full article: Adalimumab (Humira®) restores clinical response in patients with secondary
loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE …
loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE …
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully …
…, K Albertsson, H Wallin, J Bratt, S Ernestam… - Annals of the …, 2012 - ard.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …